Low-dose zinc therapy for maintenance treatment of Wilson's disease
Mayet, I.Y.
Clinical Pharmacy 9(12): 951-953
1990
ISSN/ISBN: 0278-2677 PMID: 2292179 Document Number: 351612
Document emailed within 1 workday
Related Documents
Alexiou, D.; Hatzis, T.; Koutselinis, A. 1985: Maintenance treatment of Wilson's disease with oral zinc. Apropos of a child treated for 4 years Archives Francaises de Pediatrie 42(6): 447-449Yuzbasiyan-Gurkan, V.; Brewer, G.J.; Abrams, G.D.; Main, B.; Giacherio, D. 1989: Treatment of Wilson's disease with zinc. V. Changes in serum levels of lipase, amylase, and alkaline phosphatase in patients with Wilson's disease Journal of Laboratory and Clinical Medicine 114(5): 520-526
Lee, D.Y.; Brewer, G.J.; Wang, Y.X. 1989: Treatment of Wilson's disease with zinc. VII. Protection of the liver from copper toxicity by zinc-induced metallothionein in a rat model Journal of Laboratory and Clinical Medicine 114(6): 639-645
Nagy, J.; Vajna, M.; Dévényi, L.; Zelkó, R. 2004: Zinc sulphate release and morphology of matrices prepared for the individual therapy of Wilson's disease Die Pharmazie 59(4): 327-328
Dastych, M. 1999: Serum levels of zinc, copper and selenium in patients with Wilson's disease treated with zinc Vnitrni Lekarstvi 45(4): 217-219
Ellis, C.N.; Fradin, M.S.; Hamilton, T.A.; Voorhees, J.J. 1995: Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy Archives of Dermatology 131(7): 791-795
McQuaid, A.; Lamand, M.; Mason, J. 1992: The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy Journal of Laboratory and Clinical Medicine 119(6): 744-750
Arase, Y. 2015: Prolonged maintenance therapy by low dose interferon for HCV patients with chronic liver disease Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 284-289
Mishra, D.; Kalra, V.; Seth, R. 2008: Failure of prophylactic zinc in Wilson disease Indian Pediatrics 45(2): 151-153
Lee, H.H.; Hill, G.M.; Sikha, V.K.; Brewer, G.J.; Prasad, A.S.; Owyang, C. 1990: Pancreaticobiliary secretion of zinc and copper in normal persons and patients with Wilson's disease Journal of Laboratory and Clinical Medicine 116(3): 283-288
Kaur, U.; Bambery, P.; Bhushnurmath, S.R.; Deodhar, S.D.; Dilawari, J.B. 1988: Successful long term oral zinc in florid Wilson's disease: a case report Tropical and Geographical Medicine 40(2): 161-165
Degli Esposti, A.; Antener, I.; Ambrosioni, G.; Bonfiglioli, G. 1976: Wilson's disease. Summary of studies carried out in a family group with Wilson's disease. Significance of amino-acid balance in homo and heterozygotes for the detection of liver damage Minerva Pediatrica 28(34): 2063-2086
Smolarek, C.; Stremmel, W. 1999: Therapy of Wilson disease Zeitschrift für Gastroenterologie 37(4): 293-300
Kamoun, P.; Cadoudal, M.; Rabier, D.; Jérôme, H. 1986: Detection of Wilson's disease in sibs of a patient with Wilson's disease Clinical Chemistry 32(2): 392
Miyauchi, Y.; Mii, Y.; Morishita, T.; Miura, S.; Honoki, K.; Aoki, M.; Kido, A.; Tamai, S.; Hino, M.; Nomura, Y.; Nakanishi, E. 1996: A device for rapid elevation of plasma methotrexate (MTX) concentration and its maintenance in high-dose MTX therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(5): 595-599
Hartl, J.; Hauftová, D. 1970: Therapy of neurologic manifestations of Wilson's disease using penicillamine Ceskoslovenska Neurologie 33(2): 89-93
Skeen, M.B. 1992: Wilson disease--penicillamine therapy and late presentation Annals of Internal Medicine 116(5): 424; Author Reply 425
Cunego, A.; Chiauzzi, R.; De Luca, D. 1980: Wilson's disease: physiopathology, clinical aspects and therapy Giornale di Clinica Medica 61(6): 453-472
Recchia, F.; Cesta, A.; Rea, S. 2003: Low dose interleukin-2 and 13-cis-retinoic acid as maintenance therapy in patients with solid tumors responsive to chemotherapy Journal of Experimental and Clinical Cancer Research: Cr 22(4 Suppl): 135-143
Fujimoto, T.; Sasaki, K.; Goya, N. 1978: Maintenance therapy of intermittent high-dose methotrexate in acute childhood leukemia--4-year survivals Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 41(4): 810-812